ETF TV

How can investors support cancer research with ETFs?

ETF TV’s weekly episodes cover the latest ETF listings and breaking news, alongside interviews with the people behind the ETF headlines.

For this week’s episode of ETF TV, hosts Margareta Hricova and Deborah Fuhr speak to Paul Kim, CEO & Cofounder of Simplify and Victoria Wolodzko, Senior Vice President at Susan G. Komen about the new actively managed Simplify Health Care ETF [PINK] which will donate the profits to the Susan G. Komen® organization.

We begin the episode with Kim explaining why he decided to create the Simplify Healthcare ETF [PINK] and what companies the ETF is focused on.

Woldodzko then shares the backstory of the Susan G. Komen organisation, including who they invest in and advocate for, as well as some of their standout stats. She also informs us about the number of people impacted by breast cancer in the US, as well as the discrepancies in diagnosis and treatment being a key driver behind the organisation’s research.

We then hear how the global pandemic has impacted the organisation, with both the setbacks they have received, such as delays in biomedical research, as well as how hospitals have adapted to the new way of life with technological advancements, like telehealth.

Woldodsko then goes into detail about the type of research and what the organisation is looking to fund next year, including offering grants to academic scientists and funding young talent in the field.

The interview is concluded by Kim sharing his plans to list any further ETFs, then finally Deborah gives her update on the ETF industry and any new listings.

You can donate at komen.org.

Watch the full video below.

 

 

Disclaimer Past performance is not a reliable indicator of future results.

CMC Markets is an execution-only service provider. The material (whether or not it states any opinions) is for general information purposes only, and does not take into account your personal circumstances or objectives. Nothing in this material is (or should be considered to be) financial, investment or other advice on which reliance should be placed. No opinion given in the material constitutes a recommendation by CMC Markets or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person.

The material has not been prepared in accordance with legal requirements designed to promote the independence of investment research. Although we are not specifically prevented from dealing before providing this material, we do not seek to take advantage of the material prior to its dissemination.

CMC Markets does not endorse or offer opinion on the trading strategies used by the author. Their trading strategies do not guarantee any return and CMC Markets shall not be held responsible for any loss that you may incur, either directly or indirectly, arising from any investment based on any information contained herein.

*Tax treatment depends on individual circumstances and can change or may differ in a jurisdiction other than the UK.

Continue reading for FREE

Latest articles